 SOUTH SAN FRANCISCO, Calif., Dec. 15, 2020 GLOBE NEWSWIRE -- Fluidigm Corporation Nasdaq:FLDM, an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the appointment of Dr. Ana K. Stankovic, MD, PhD, MSPH, to the companys Board of Directors. Dr. Stankovic is a seasoned leader with more than 30 years of research and development experience in academic, government, in vitro diagnostic and device industry settings. 